First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Urology, 'Martha-Maria' Hospital Nuremberg, Nuremberg, Germany.
J Urol. 2021 Apr;205(4):1009-1017. doi: 10.1097/JU.0000000000001577. Epub 2020 Dec 15.
Erectile dysfunction has a lower prevalence in renal transplant recipients compared to dialysis patients. Despite this observation, the effect of renal transplantation on erectile function remains unknown. We aimed to assess the role of renal transplantation on erectile function and to determine potential factors improving or deteriorating erectile dysfunction.
We conducted a systematic review and random effects meta-analysis of observational studies comparing erectile function preoperatively and postoperatively in renal transplant recipients (PROSPERO ID: CRD42020189580). Records reporting relevant outcomes were identified through search of PubMed®, Embase®, Cochrane Library and Scopus® databases from inception to September 2020. Judgment of the strength of evidence was performed with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
We included 20 studies with 1,695 renal transplant recipients. At postoperative evaluation the number of patients with erectile dysfunction was reduced (RR 1.21, 95% CI 1.02-1.45, I=88%). Renal transplant recipients reported an improvement in erectile function (RR 2.53, 95% CI 1.44-4.44, I=90%) and the mean International Index of Erectile Function score increased by 3.04 points (95% CI 0.63-5.45, I=96%) after renal transplantation. These effects were not demonstrated in the sensitivity analysis. In individuals reporting severe erectile dysfunction, no favorable effect of renal transplantation was observed (RR 1.51, 95% CI 0.85-2.68, I=33%). For all outcomes the strength of evidence was considered low or very low due to methodological concerns and high heterogeneity among the included studies.
Renal transplantation improves erectile function and the risk of erectile dysfunction reduces postoperatively compared to preoperatively. However, evidence on the matter is mostly based on low quality data. More studies with standardized outcomes are needed to validate and strengthen our findings.
与透析患者相比,接受肾移植的患者勃起功能障碍的患病率较低。尽管有这种观察结果,但肾移植对勃起功能的影响仍不清楚。我们旨在评估肾移植对勃起功能的作用,并确定改善或恶化勃起功能障碍的潜在因素。
我们对比较肾移植受者术前和术后勃起功能的观察性研究进行了系统评价和随机效应荟萃分析(PROSPERO ID:CRD42020189580)。通过搜索 PubMed®、Embase®、Cochrane 图书馆和 Scopus®数据库,从成立到 2020 年 9 月,确定了报告相关结果的记录。使用推荐评估、制定和评估(GRADE)方法判断证据强度。
我们纳入了 20 项研究,共 1695 例肾移植受者。在术后评估时,勃起功能障碍患者的数量减少(RR 1.21,95%CI 1.02-1.45,I=88%)。肾移植受者报告勃起功能得到改善(RR 2.53,95%CI 1.44-4.44,I=90%),国际勃起功能指数评分平均增加 3.04 分(95%CI 0.63-5.45,I=96%)。这些效果在敏感性分析中未得到证实。在报告严重勃起功能障碍的个体中,肾移植没有有利影响(RR 1.51,95%CI 0.85-2.68,I=33%)。由于方法学问题和纳入研究之间存在高度异质性,所有结局的证据强度均被认为较低或极低。
与术前相比,肾移植术后可改善勃起功能,勃起功能障碍的风险降低。然而,关于这一问题的证据主要基于低质量的数据。需要更多具有标准化结局的研究来验证和加强我们的发现。